
Biotechnology company.
Staff Quality Engineer, CAPA Program #4693
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
GRAIL is headquartered in the bay area of California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.
For more information, please visit grail.com
Reporting to the Senior Director, Quality Strategy & Operational Excellence, the Staff Quality Engineer is responsible for leading, executing, maintaining, and improving the Corrective and Preventive Action (CAPA) program in accordance with ISO 13485:2016 and 21 CFR Part 820, Quality Management System Regulation. This role additionally supports the Nonconformance (NCR) program, Quality Management Review (QMR), clinical laboratory Quality Monitoring and Improvement (QMI), Quality Indices (QI), Change Control, Quality Planning, clinical laboratory licensure/certification, internal and external audits, and other activities as assigned. This person will work cross-functionally to ensure alignment and implementation of QMS programs while adhering to strict project and program timelines and deliverables. The person in this role consistently applies critical thinking skills and good judgment to solve complex problems, effectively communicating status and recommendations to management.
This role is based at our Durham, North Carolina, office. It offers a flexible work arrangement, with the ability to work from GRAIL's office or from home. Our current flexible work arrangement policy requires that a minimum of 60%, or 24 hours, of your total work week be on-site. Your specific schedule, determined in collaboration with your manager, will align with team and business needs and could exceed the 60% requirement for the site.
浏览量
0
申请点击
0
Mock Apply
0
收藏
0
相似职位

Senior ATE Wafer Test Engineer
Nokia · United States, US

Senior Principal Design Quality Engineer
Baxter International · Round Lake, Illinois

Principal Hardware Design & Test Engineer
Collins Aerospace (RTX) · 2 Locations

Senior Automation Test Engineer, Web
Otter.ai · Mountain View, CA

Sr. Staff Design Quality Engineer
Becton Dickinson · USA NC - Durham - Roche Drive
关于Grail

Grail
Series CGRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
201-500
员工数
Menlo Park
总部位置
$3.2B
企业估值
评价
10条评价
3.9
10条评价
工作生活平衡
3.8
薪酬
3.5
企业文化
4.2
职业发展
3.0
管理层
3.2
72%
推荐率
优点
Good work-life balance
Supportive team and management
Innovative and challenging projects
缺点
Heavy workload and overwhelming at times
Limited career advancement opportunities
Management and communication issues
薪资范围
135个数据点
Senior/L5
Senior/L5 · Senior Analytical Engineer
3份报告
$187,544
年薪总额
基本工资
$163,039
股票
-
奖金
-
$180,790
$195,500
面试评价
4条评价
难度
2.8
/ 5
时长
14-28周
体验
正面 25%
中性 75%
负面 0%
面试流程
1
Application Review
2
Recruiter Screen
3
Technical Phone Screen
4
Onsite/Virtual Interviews
5
Team Matching
6
Offer
常见问题
Technical Knowledge
Behavioral/STAR
Past Experience
Coding/Algorithm
最新动态
GRAIL (NASDAQ: GRAL) outlines CEO transition, director elections in 2026 proxy - Stock Titan
Stock Titan
News
·
1w ago
My Grail Everyday Watch Gets the Perfect Summer Revamp - Gear Patrol
Gear Patrol
News
·
1w ago
Lilly's $2.25B bet chases genetic medicine's 'holy grail' - FirstWord Pharma
FirstWord Pharma
News
·
1w ago
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’ - BioSpace
BioSpace
News
·
1w ago